SAN DIEGO, CA – January 22, 2025 – Antharis Therapeutics, a biopharmaceutical company advancing cutting-edge immunotherapeutic treatments in oncology, proudly announces that its founder, CEO, and Chairman, Dr. Raphael Ribeiro-Pinaud, has been selected and honored as the “Most Iconic Business Leader of 2025” by The Executive Lens. This accolade recognizes Dr. Ribeiro-Pinaud’s exceptional leadership, vision and groundbreaking contributions to the biopharmaceutical industry, particularly in the oncology and immuno-oncology sectors.
Under Dr. Ribeiro-Pinaud’s leadership, Antharis Therapeutics has emerged as a transformative force in cancer treatment, focusing on the development of monoclonal antibody (mAb) and antibody-drug conjugate (ADC) therapies. The company’s precision medicine approach addresses a number of aggressive and rare solid cancers, offering hope for improved patient outcomes.
Dr. Ribeiro-Pinaud’s career reflects a rare blend of deep scientific expertise and strategic business acumen. His ability to bridge scientific, financial, and entrepreneurial disciplines has established Antharis as a leading emerging company advancing cutting-edge therapies for unmet medical needs.
Learn more about Dr. Ribeiro-Pinaud’s inspiring journey and the innovative work driving Antharis’ success by reading the full article here: Read Full Article.
About Antharis Therapeutics
Antharis Therapeutics is a leading biopharmaceutical company focused on developing innovative monoclonal antibody therapies for oncology and other critical medical fields. The company’s unique approach to cancer treatment leverages, among a number of strategies, the power of immuno-oncology, enhancing the body’s immune response to fight cancer. With a robust pipeline of therapies and a multidisciplinary team of experts, Antharis is dedicated to transforming the future of healthcare by delivering safe, effective, and life-changing treatments to patients worldwide. For more information, please visit www.antharistherapeutics.com.
